Starting Care for Attention Deficit Hyperactivity Disorder 2022-23 Edition

When comparing plans, small differences between scores are expected. The larger differences are important.

Starting Care for Attention Deficit Hyperactivity Disorder

  • (Worse)
    0%
  • (Better)
    100%
Kaiser Permanente - Northern California - HMO 74%
Horizontal bar, 74 units
Horizontal bar, 74 units
Kaiser Permanente - Southern California - HMO 69%
Horizontal bar, 69 units
Horizontal bar, 69 units
Western Health Advantage - HMO 46%
Horizontal bar, 46 units
UnitedHealthcare Insurance Co., Inc. - PPO 43%
Horizontal bar, 43 units
Aetna - PPO 40%
Horizontal bar, 40 units
Health Net Life Insurance Company - PPO 40%
Horizontal bar, 40 units
Anthem Blue Cross - PPO 39%
Horizontal bar, 39 units
Blue Shield of California/Blue Shield Life - PPO 39%
Horizontal bar, 39 units
CIGNA - HMO 38%
Horizontal bar, 38 units
Anthem Blue Cross - HMO 37%
Horizontal bar, 37 units
CIGNA - PPO 37%
Horizontal bar, 37 units
Aetna Health of California, Inc. - HMO 36%
Horizontal bar, 36 units
Health Net of California, Inc. - HMO 33%
Horizontal bar, 33 units
Blue Shield of California - HMO 31%
Horizontal bar, 31 units
Sharp Health Plan - HMO 29%
Horizontal bar, 29 units
UnitedHealthcare of California - HMO 24%
Horizontal bar, 24 units
Score for top health plans nationwide  48%       
Score that ranks a health plan in the top 10% of all commercial health plans in the US.

Data Disclaimer  
The source for data contained in this publication is Quality Compass®2022 and is used with the permission of the National Committee for Quality Assurance (NCQA). Quality Compass® 2022 includes certain Consumer Assessment of Healthcare Providers and Systems (CAHPS®) data. Any data display, analysis, interpretation, or conclusion based on these data is solely that of the authors, and NCQA specifically disclaims responsibility for any such display, analysis, interpretation, or conclusion. Quality Compass is a registered trademark of NCQA. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Users of the data shall not have the right to alter, enhance, or otherwise modify the data. Anyone desiring to use or reproduce the data without modification for a noncommercial purpose may do so without obtaining any approval from NCQA. All commercial uses must be approved by NCQA and are subject to a license at the discretion of NCQA. Use by health care providers in connection with their own practices is not commercial use. A "commercial use" refers to any sale, license, or distribution of the data for commercial gain, or incorporation of the data into any product or service that is sold, licensed, or distributed for commercial gain, even if there is no actual charge for inclusion of the data. ©2004-2022 National Committee for Quality Assurance, all rights reserved.

311.110/311.210